Takashi Nishimura

机构：Hyogo Medical University, Hyogo Prefectural Nishinomiya Hospital, Hyogo University · ORCID：0000-0002-5517-8303

发表论文 701 篇 · 总被引 16821 次 · h-index 58

代表论文

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study (2025 · Liver International · 被引 8)
Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
Prognosis of Hepatectomy versus Systemic Chemotherapy Based on Oncological Resectability Criteria for Borderline Resectable Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)
Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab (2025 · Hepatology Research · 被引 4)
Impact of time‐of‐day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study (2025 · Hepatology Research · 被引 4)
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient (2025 · Oncology · 被引 4)